Livzon Pharmaceutical Group details extensive A share repurchases

Livzon Pharmaceutical Group announced significant A share repurchase activity, with multiple transactions occurring throughout late 2024 and 2025. On September 11, 2025, the company repurchased 126,700 A shares on the Shenzhen Stock Exchange at prices ranging from RMB 38.71 to RMB 39.84, totaling RMB 4,997,640. These repurchased shares will be held as treasury stock. The company's total issued A shares as of September 11, 2025, stand at 604,293,313.

The report also detailed numerous A share repurchases between December 2024 and September 2025, with daily volumes ranging from 1,700 to 561,400 shares. These transactions were executed at varying prices, such as RMB 37.75 on December 25, 2024, and RMB 39.44 on September 11, 2025, demonstrating consistent market activity. The company confirmed that all necessary regulatory approvals and legal requirements for these repurchases have been met.